Hangzhou AGS Medtech Co (SHSE:688581) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688581 Hangzhou AGS Medtech Co Ltd SHSE:688581
90 GF Score
Price ¥53.36
GF Value ¥78.43
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Hangzhou AGS Medtech Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:688581
90GF Score
Hangzhou AGS Medtech Co Ltd SHSE:688581
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hangzhou AGS Medtech Co (SHSE:688581) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou AGS Medtech Co stock appears to be undervalued. The current stock price of ¥53.36 is trading 32% below its estimated GF Value™ of ¥78.43. GuruFocus considers Hangzhou AGS Medtech Co to be Significantly Undervalued.

Key valuation signals for SHSE:688581:

  • Dividends Received:
  • GF Value™: ¥78.43 vs. price of ¥53.36 (32% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688581 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou AGS Medtech Co Business Description

Address No. 389 Xingzhong Road, Linping District, Zhejiang Province, Hangzhou, CHN, 311199
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and provide patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.
90GF Score

Get the complete analysis for SHSE:688581

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥53.36
Price
¥78.43
GF Value